NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Small-cap Stocks Show Resilience in April

The small-cap segment of the Indian stock market showed remarkable resilience in April, outperforming its large- and mid-cap peers by a wide margin amid improving market sentiment, valuation comfort, and renewed earnings optimism. The Nifty Smallcap 250 finished the first month of FY27 with a solid gain of 17.10%, outperforming both the Nifty 50 and the Nifty Midcap 150, which advanced 7.3% and 13.22%, respectively, during the same period.

This sharp rebound pushed the index to its highest level since January and helped it recover all of the war-driven losses. The outperformance was largely driven by heavy buying from domestic investors after they had largely ignored the segment for nearly nine months between July 2025 and March 2026. The prolonged correction, which was later compounded by Middle East worries, dragged a majority of these stocks to multi-year lows, making valuations cheaper and turning them into more attractive bets compared to their peers.

SegmentApril GainRecent Best Monthly Performance
Nifty Smallcap 25017.10%21.2% (May 2014)
Nifty 507.3%-
Nifty Midcap 15013.22%-

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

March mutual fund data also showed a sharp uptick in equity fund inflows, with flows into small-cap mutual funds surging 61% month-on-month to ₹6,300 crore. Although investing in small-cap stocks is relatively riskier compared to large-caps, investors are now increasingly choosing the more disciplined route through mutual funds. Domestic institutional investors have pumped ₹51,000 crore in April, as per the exchange data, while the selling by the FPIs has extended into April as they pulled out ₹60,847 crore. However, the selling was slowed when compared to ₹1.17 lakh crore outflows seen in March, NDSL data showed.

Among individual stocks, 35 constituents of the index delivered massive gains, with HFCL leading the list after surging a sharp 71%, marking its best monthly rally since December 2007. The strong rebound comes after a prolonged stretch of stagnation, with the shares remaining largely flat from June 2025 through the end of last month. Ola Electric also displayed similar strength, recovering 60.35%, its best monthly performance since listing, while the rally helped end its six-month losing run.

Other notable gainers include Cohance Lifesciences, which regained momentum after suffering losses for eight straight months, ending April with a stellar 60% spike. Cemindia Projects also rallied, ending the month with a 59% surge. Capital goods stocks such as Schneider Electric Infrastructure and Elecon Engineering zoomed 47% and 43%, respectively. Bandhan Bank shares climbed 42%, while Meesho saw its shares surge 37.6%, bringing much-needed relief to shareholders. Urban Company rewarded shareholders with a 27.60% return, building on an 11% jump in March.

Investor Takeaway

Investors should consider allocating to small-cap stocks for potential long-term gains.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.